Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation

Inclusion Criteria: If female, must either be not of childbearing potential or if they are of childbearing potential must have a negative urine pregnancy test. * Wound size greater than 1x1 cm * Wounds must be ≥5 cm away from all other wounds * Wound size must not be diminished in size greater than 10% between enrollment in study and the prescreening * Participant agrees to participate in follow-up evaluation * Participant must be able to read and understand informed consent, and sign the informed consent Exclusion Criteria: * Concurrent participation in another clinical trial that involves an investigational drug or device that would interfere with this study * Participant is to receive another topical antimicrobial agent other than the study dressing * Participant with sensitivity or adverse reactions to silver or zinc * Pregnancy or nursing an infant or child * Immunosuppression * Active or systemic infection * Peripheral vascular occlusive disease * Collagen vascular disease * Connective tissue disease * Diabetes * Venous stasis ulcers * Participant undergoing active cancer chemotherapy * Chronic steroid use * Decision impairment